Regional Analysis
Global Diagnostic Radioisotopes Market- Regional Insights
- North America is expected to be the largest market for diagnostic radioisotopes during the forecast period, accounting for over 41.5% of the market share in 2023. The growth of the market in North America is attributed to the high healthcare expenditure and developed healthcare infrastructure.
- Europe is expected to be the second-largest market for diagnostic radioisotopes, accounting for over 28.2% of the market share in 2023. The growth of the market in is attributed to the rising cancer cases and product launches.
- Asia Pacific is expected to be the fastest-growing market for diagnostic radioisotopes, with a CAGR of over 22.6% during the forecast period. The growth of the market in Asia Pacific is attributed to the large patient pool and increasing awareness.
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
U.S.: 
U.K. : 
India : 
